Showing results (151-160 of 170) with videos related to

Sort By:
Pageof 17
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 25, 2014
Transmission of methicillin-resistant Staphylococcus aureus via deceased donor liver transplantation confirmed by whole genome sequencingD R Altman, R Sebra, J Hand, et al.
Clinical Transplantation|February 18, 2009
Long-term outcomes of donation after cardiac death liver allografts from a single centerJustin H Nguyen, Hugo Bonatti, Rolland C Dickson, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 3, 2006
Peritonitis after liver transplantation: Incidence, risk factors, microbiology profiles, and outcomeSurakit Pungpapong, Salvador Alvarez, Walter C Hellinger, et al.
Journal of Clinical Apheresis|December 11, 2025
A Web-Based Calculator for Hematopoietic Progenitor Cell Collections: App Development and Retrospective AssessmentMaxwell T Roth, Jun Liu, Sanjana B Shah, et al.
Acta Neuropathologica|January 4, 2020
POGLUT1 biallelic mutations cause myopathy with reduced satellite cells, α-dystroglycan hypoglycosylation and a distinctive radiological patternE Servián-Morilla, M Cabrera-Serrano, K Johnson, et al.
Journal for Immunotherapy of Cancer|April 15, 2025
Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for stage III melanoma: outcomes and the impact of the microbiome from the NeoACTIVATE trialMatthew S Block, Garth D Nelson, Jun Chen, et al.
Circulation. Genomic and Precision Medicine|July 16, 2019
Subtype Specificity of Genetic Loci Associated With Stroke in 16 664 Cases and 32 792 ControlsMatthew Traylor, Christopher D Anderson, Loes C A Rutten-Jacobs, et al.
Nature Communications|February 16, 2024
Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trialTina J Hieken, Garth D Nelson, Thomas J Flotte, et al.
Neuro-Oncology|June 28, 2025
Mesothelin is a surface antigen present on human meningioma and can be effectively targeted by CAR T-cellsRishab Ramapriyan, Fred G Barker, Leland G Richardson, et al.
The Lancet. Neurology|March 28, 2021
Genetic basis of lacunar stroke: a pooled analysis of individual patient data and genome-wide association studiesMatthew Traylor, Elodie Persyn, Liisa Tomppo, et al.
Pageof 17